Fungus dubbed ‘mummy's curse' could make a powerful cancer drug, new study reveals
Researchers believe that a fungus thought to be found in ancient tombs may provide a valuable new tool in the fight against cancer.
The fungus Aspergillus flavus, sometimes dubbed the 'mummy's curse' for its potential link to the deaths of archaeologists who excavated famous tombs like that of King Tutankhamen in Egypt, shows promise in stopping cancers such as leukemia, according to a new study published Monday in Nature Chemical Biology from a team of scientists led by the University of Pennsylvania.
'Fungi gave us penicillin,' Sherry Gao, associate professor in chemical and biomolecular engineering and bioengineering at Penn, a senior author on the study, said in a statement. 'These results show that many more medicines derived from natural products remain to be found.'
Over the course of their research, the scientists isolated and purified a new class of molecules derived from the fungus, asperigimycins, and tested them against common cancers in breast, liver, and lung cells.
Even with no modification, two of the four asperigimycins in the experiment had 'potent' effects against leukemia cells, according to the university.
Another variation, to which scientists added a fatty lipid molecule, performed as well as the longstanding Food and Drug Administration-approved leukemia drugs cytarabine and daunorubicin, the university added.
Researchers believe these molecules, created inside the fungus's cellular machinery then modified by the study's authors, block some of the mechanisms of cell division, halting the unchecked cell growth that causes cancer.
'Cancer cells divide uncontrollably,' Gao added in the statement. 'These compounds block the formation of microtubules, which are essential for cell division.'
Aspergillus flavus, which is commonly found in soil, can lead to lung infections in humans, especially among those with compromised immune systems, and infects a variety of agricultural crops.
As a result, it is one of the most frequently isolated mold species in agriculture and medicine, according to Popular Science.
The Penn team, which also included researchers from Rice University, the University of Pittsburg, the University of Texas, Washington University of St. Louis, Baylor College of Medicine, and the University of Porto, said its research was unique because it focused on a class of peptides more commonly studied in bacteria, rather than fungus.
The research, which scientists hope to continue in animal models and potential human trials down the road, was funded by the National Institutes of Health, the biomedical research hub from which the Trump administration hopes to cut $18 billion in funding.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
1,000-year-old pre-Inca mummy discovered just half a metre below a street in Lima
The remains, identified as a woman aged 20 to 30, were wrapped in a bundle that still had visible dark brown hair. Alongside the body, archaeologists found nine ceramic vessels, including a painted bottle depicting a fisherman in a headdress - suggesting the woman belonged to the Chancay culture, a coastal fishing society that thrived between 1000 and 1470 AD. The discovery is part of an ongoing archaeological monitoring program by the national gas company Cálidda, which has recovered over 2,200 artefacts during infrastructure projects in Lima.
Yahoo
7 hours ago
- Yahoo
Confirmed: New Mexico Footprints Rewrite Timeline of Humans in America
Ancient seas left an expanse of rolling gypsum dunes known as White Sands in New Mexico, and within this surreal landscape lies evidence that humans have roamed the Americas for at least 20,000 years. While most of White Sands is protected as a national park, the US army controls part of it as a missile range. It was within this section that researchers found clay footprints, preserved below the gypsum, that have rewritten the timeline of human presence in the Americas. Previously, we thought humans arrived in North America around 13,200 to 15,500 years ago. But a new study led by University of Arizona archeologist Vance Holliday combines evidence from mud, Ruppia seeds and pollen found in layers above and below the trace fossils, to date the footprints as being between 20,700 and 22,400 years old. This means they were trod in the last Ice Age, by people crossing a floodplain on the margins of the extinct Lake Otero that once covered around 4,140 square kilometers (1,600 square miles) of the Tularosa Basin. "Pleistocene lakes and associated biological resources in western and southwestern North America must have attracted foragers, but archaeologists have surveyed few paleolake basins," Holliday and his colleagues write. Related: The footprints were first discovered in 2021, and were dated to between 21,000 and 23,000 years ago using embedded seeds and pollen. But critics questioned this method to determine the footprints' age, since these lightweight biological materials can easily be moved in such a dynamic ecosystem. But the new paper found that analysis of mud layers backs up what the plant traces tell us. "Most of this dating of organic matter from palustrine muds complement the dating of the seeds and pollen previously reported," the authors report. "It would be serendipity in the extreme to have all these dates giving you a consistent picture that's in error," says Holliday. The research is published in Science Advances. Video: How Far Away Would You Need to Be to Survive a Nuclear Blast? What Really Killed The Neanderthals? A Space Physicist Has a Radical Idea Casino Lights Could Be Warping Your Brain to Take Risks, Scientists Warn
Yahoo
8 hours ago
- Yahoo
Fungus dubbed ‘mummy's curse' could make a powerful cancer drug, new study reveals
Researchers believe that a fungus thought to be found in ancient tombs may provide a valuable new tool in the fight against cancer. The fungus Aspergillus flavus, sometimes dubbed the 'mummy's curse' for its potential link to the deaths of archaeologists who excavated famous tombs like that of King Tutankhamen in Egypt, shows promise in stopping cancers such as leukemia, according to a new study published Monday in Nature Chemical Biology from a team of scientists led by the University of Pennsylvania. 'Fungi gave us penicillin,' Sherry Gao, associate professor in chemical and biomolecular engineering and bioengineering at Penn, a senior author on the study, said in a statement. 'These results show that many more medicines derived from natural products remain to be found.' Over the course of their research, the scientists isolated and purified a new class of molecules derived from the fungus, asperigimycins, and tested them against common cancers in breast, liver, and lung cells. Even with no modification, two of the four asperigimycins in the experiment had 'potent' effects against leukemia cells, according to the university. Another variation, to which scientists added a fatty lipid molecule, performed as well as the longstanding Food and Drug Administration-approved leukemia drugs cytarabine and daunorubicin, the university added. Researchers believe these molecules, created inside the fungus's cellular machinery then modified by the study's authors, block some of the mechanisms of cell division, halting the unchecked cell growth that causes cancer. 'Cancer cells divide uncontrollably,' Gao added in the statement. 'These compounds block the formation of microtubules, which are essential for cell division.' Aspergillus flavus, which is commonly found in soil, can lead to lung infections in humans, especially among those with compromised immune systems, and infects a variety of agricultural crops. As a result, it is one of the most frequently isolated mold species in agriculture and medicine, according to Popular Science. The Penn team, which also included researchers from Rice University, the University of Pittsburg, the University of Texas, Washington University of St. Louis, Baylor College of Medicine, and the University of Porto, said its research was unique because it focused on a class of peptides more commonly studied in bacteria, rather than fungus. The research, which scientists hope to continue in animal models and potential human trials down the road, was funded by the National Institutes of Health, the biomedical research hub from which the Trump administration hopes to cut $18 billion in funding.
